REGULATORY PERSPECTIVE OF BIOSIMILARS IN INDIA

Journal Title: Asian Journal Of Pharmaceutical Research and Development - Year 2017, Vol 5, Issue 1

Abstract

Biosimilar drugs are follow-on versions of original biopharmaceutical medicines. They are independently developed after the patent protecting the original product has expired. Biosimilars are designed to target specific components of immune system as these drugs are capable of targeting proteins in a more specific fashion, yet have lower risks of systemic sideeffects; they have considerable advantages over the older Immunomodulators. As these products are more effective Indian bio-Pharma companies carry the advantages of low cost manufacturing and a highly skilled workforce with global expertise. Biosimilar medicines are intended to have the same mechanism of action for the same diseases as the original biopharmaceutical drug. The regulatory pathway for biosimilars in India was developed jointly by Central drug standard control organisation (CDSCO) & Department of Biotechnology (DBT) through Review Committee on Genetic Manipulation (RCGM).

Authors and Affiliations

Sirisha Katla

Keywords

Related Articles

EFFECT OF RED BETEL (PIPER CROCATUM RUIZ AND PAV.) ETHANOL EXTRACT AGAINST CARBON TETRACHLORIDE INDUCE HEPATIC INJURY IN RATS

Hepatic disorder is one of a big problem in health system especially cirrhosis. Based on WHO, the prevalence of cirrhosis is 1,3% and 18th caused death about 800.000 cases. Herbal medicines are widely used in treatment a...

ANTI FERTILITY ACTIVITY OF HYDRO ALCOHOLIC EXTRACT OF TRILLIUM GOVANIANUM IN ETHINYL ESTRADIOL INDUCED ANTI FERTILITY MODEL IN RATS

Lack of fertility is in fertility were as anti-fertility is to reduce fertility. Fertility is burning issue of global as well as national public issue which are concerning the fast growth of the country. Increase rate of...

ANTI-CANCER ACTIVITY OF CEDRUS DEODARA IN 1,2-DIMETHLY HYDRAZINE (DMH) INDUCED ANTI CANCER MODEL IN RATS

Cancer is a dangerous disease of all multicellular organisms. Cancer is a serious as well as life threatening disease characterized by uncontrolled division and growth of abnormal cells in the body. In presen...

A BRIEF REVIEW ON PERIODONTAL DISEASES

Periodontal disease is a chronic inflammatory disease of the gum and tissues that surround and support the teeth. Periodontal disease is caused by bacteria in dental plaque, the sticky substance that forms on your teeth...

FORMULATION AND EVALUATION OF GLIBENCLAMIDE TABLET USING SOLID DISPERSION WITH VARIOUS POLYMERS

The aim of the present study is to enhance the solubility of water insoluble drug, Glibenclamide by preparing solid dispersion using various polymers and further formulating its tablet. Solid dispersion...

Download PDF file
  • EP ID EP303013
  • DOI -
  • Views 176
  • Downloads 0

How To Cite

Sirisha Katla (2017). REGULATORY PERSPECTIVE OF BIOSIMILARS IN INDIA. Asian Journal Of Pharmaceutical Research and Development, 5(1), 1-9. https://europub.co.uk/articles/-A-303013